A Study to Evaluate the Pharmacokinetic Interaction and the Safety of AD-231A and AD-231B and AD-231C

Status:
NOT_YET_RECRUITING

Trial end date:
2026-02-22

Target enrollment:

Participant gender:

To evaluate the pharmacokinetic interactions of AD-231A, AD-231B, and AD-231C in healthy adult volunteers.

PHASE1

Addpharma Inc.